Establishment of a Public-Private Partnership (PPP) to Support Therapy Selection and Testing within RECOVER-TLC

RECOVER-TLC Abstract for FNIH OT Proposal Establishment of a Public Private Partnership (PPP) to Support RECOVER-TLC September 18, 2024 The NIH will collaborate with the FNIH to create a long COVID-19 public-private partnership (PPP) to accelerate the development of therapeutics, consistent with the FNIH’s own mission and the

Congressional statute by which the FNIH was established to support the NIH in its mission and to advance collaboration with biomedical researchers from universities, industry, nonprofit organizations, and other federal agencies, including the US Food and Drug Administration (FDA). The overarching goal

of the FNIH in this new PPP is to support the NIH in designing and implementing a strategic and coordinated cross-sector approach to address the current long COVID challenges and lack of effective therapies. This PPP is now known as RECOVER-TLC, the NIH Researching COVID to Enhance Recovery- Treating Long COVID (RECOVER-TLC).